KRAS and colorectal cancer: Kamran et al. have also compared pre‐ and post‐CRT mutations and reported that gene mutation status occurring frequently in colorectal cancer such as TP53, KRAS, and APC is grossly similar between pre‐ and post‐CRT samples.37